Oryon Cell Therapies raises $21 million in Series A funding, increasing total financing to $42 million. Led by investors Neuro.VC and Byers Capital, the funding will support advanced clinical trials for neuron replacement therapies.
Amount Raised
$21 Million
Round Type
Series A
Investors
Description
Oryon Cell Therapies has closed a new $21 million tranche of its Series A financing, bringing its total funding to $42 million. The funds will support the ongoing Phase 1b/2a clinical trial for its neuron replacement therapy program. Investors include Neuro.VC and Byers Capital. The company aims to advance its solutions for Parkinson’s disease and other neurodegenerative disorders.
Quick answer
Oryon Cell Therapies raised $21 Million in a Series A round, dated March 23, 2026. Investors: Neuro.Vc and Byers Capital.
- How much did Oryon Cell Therapies raise?
- Oryon Cell Therapies raised $21 Million in a Series A round on March 23, 2026.
- Who invested in Oryon Cell Therapies?
- Neuro.Vc and Byers Capital are named as investors in this round.
- What does Oryon Cell Therapies do?
- Oryon Cell Therapies is a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Oryon Cell Therapies that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- Remedium Bio raised $10M (Series A) on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Aura Biosciences, Inc. raised $238M (Post-IPO Equity) on May 4, 2026.
- Cue Biopharma raised $30M on May 4, 2026.
- mbiomics raised $35M (Series A) on April 29, 2026.
Who to call at Oryon Cell Therapies, and when
A new round usually means Oryon Cell Therapies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oryon Cell Therapies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oryon Cell Therapies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oryon Cell Therapies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oryon Cell Therapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansOryon Cell Therapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.